MRNA-CAP-ANALOGA

European patent · EP2297175 · In force

Register entry

Publication number
EP2297175
Application number
EP09759412
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jun 4, 2009
Published
Mar 23, 2011
Granted
Aug 7, 2013
Protection ends at the latest
Jun 3, 2029
Next annual fee due
Jun 30, 2027
IPC classes
C07H 21/00 (2006.01)
C07H 21/02 (2006.01)
Priority
PL 38538808 06.06.2008
PCT application
PCT/US2009/046249 04.06.2009
PCT publication
WO2009/149253 10.12.2009
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 01.07.2026

  2. Jul 1, 2025

    Next annual fee due on

    Next annual fee due on
    30.06.2025 → 30.06.2026

    Published in Swissreg on 01.07.2025

  3. Jul 1, 2024

    Change

    Published in Swissreg on 01.07.2024

  4. Jul 1, 2023

    Change

    Published in Swissreg on 01.07.2023

  5. Jul 1, 2022

    Change

    Published in Swissreg on 01.07.2022

  6. Aug 15, 2013

    Agent entered

    Representative
    Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich

    Published in Swissreg on 15.08.2013

  7. Aug 7, 2013

    Granted

    Published in Swissreg on 07.08.2013

Parties

Inventor

KOWALSKA, Joanna

PL-26-600 Radom, PL

JEMIELITY, Jacek

PL-01-451 Warsaw, PL

DARZYNKIEWICZ, Edward

PL-03-721 Warsaw, PL

RHOADS, Robert, E.

Shreveport LA 71106, US

LUKASZEWICZ, Maciej

PL-02-089 Warsaw, PL

ZUBEREK, Joanna

PL-02-089 Warsaw, PL

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.